Overview

Buffered Anesthetic Solution in the Treatment of Mandibular Primary Molars

Status:
Active, not recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
In a prospective, randomized clinical trial, triple-blind, split mouth study, 40 children aged between 6 to 10 with bilateral mandibular primary molars diagnosed with pulpitis The test agent will be 2% lidocaine with epinephrine 1:8000 buffered with sodium bicarbonate 8.4% at a ratio of 1/10, as opposed to the control agent, which will be non- buffered 2% lidocaine 1:80,000 with epinephrine. Pain during IANB administration and the effectiveness of anesthesia will be assessed using subjective wong baker visual analogue scale, objective sound, eye, and motor (SEM) scale, and physiological pain scale (pulse rate) using pulse oximeter. We will confirm the onset of anesthesia after lip, tongue numbing by probing the gingiva until there is no pain. Endo ice will be used to assess the onset of pulp anesthesia
Phase:
Phase 4
Details
Lead Sponsor:
Damascus University
Treatments:
Lidocaine